GENKY DRUGSTORES CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,250 JPY | +3.48% |
|
+1.79% | +14.47% |
| Sales 2024 * | 185B 1.19B | Sales 2025 * | 199B 1.29B | Capitalization | 91.76B 593M |
|---|---|---|---|---|---|
| Net income 2024 * | 6.14B 39.64M | Net income 2025 * | 6.62B 42.75M | EV / Sales 2024 * | 0.65 x |
| Net Debt 2024 * | 28B 181M | Net Debt 2025 * | 30.3B 196M | EV / Sales 2025 * | 0.61 x |
| P/E ratio 2024 * |
15
x | P/E ratio 2025 * |
14
x | Employees | - |
| Yield 2024 * |
0.41% | Yield 2025 * |
0.43% | Free-Float | 46.89% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +3.48% | ||
| 1 week | +1.79% | ||
| Current month | -5.02% | ||
| 1 month | -5.02% | ||
| 3 months | +7.94% | ||
| 6 months | +22.79% | ||
| Current year | +14.47% |
1 week
5 920.00
6 300.00
1 month
5 920.006 720.00
Current year
5 310.006 840.00
1 year
3 925.006 840.00
3 years
2 965.006 840.00
5 years
1 427.006 840.00
10 years
1 427.006 840.00
| Managers | Title | Age | Since |
|---|---|---|---|
Takeshi Tsunemi
DFI | Director of Finance/CFO | - | - |
Kenichi Fujinaga
PSD | President | 61 | 17-12-20 |
Junya Imai
BRD | Director/Board Member | 47 | 17-11-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kenichi Fujinaga
PSD | President | 61 | 17-12-20 |
| Director/Board Member | 55 | 17-12-20 | |
| Director/Board Member | 52 | 17-12-20 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.15% | 10 M€ | +8.85% | ||
| 0.01% | 81 M€ | +12.92% | ||
| 0.01% | 18 M€ | +16.15% | - | |
| 0.01% | 20,721 M€ | +12.51% | - | |
| 0.01% | 66,066 M€ | +13.68% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 6,250 | +3.48% | 31 200 |
| 24-04-22 | 6,040 | +0.50% | 24,700 |
| 24-04-19 | 6,010 | -3.22% | 37,000 |
| 24-04-18 | 6,210 | +1.97% | 9,500 |
| 24-04-17 | 6,090 | -0.81% | 15,600 |
Delayed Quote Japan Exchange, April 23, 2024 at 02:00 am EDT
More quotes
Genky DrugStores Co Ltd is mainly engaged in the management of group companies and the related business. The Company is mainly engaged in the retail of medicines, cosmetics, miscellaneous goods, foods and others.
Sector
Drug Retailers
Calendar
2024-04-24
- Q3 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
6,040
JPY
Average target price
7,600
JPY
Spread / Average Target
+25.83%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.47% | 593M | |
| -30.22% | 15.72B | |
| -38.36% | 9.56B | |
| -10.39% | 6.13B | |
| +7.77% | 6.02B | |
| -36.56% | 5.46B | |
| +2.19% | 4.85B | |
| +48.75% | 4.24B | |
| -11.71% | 3.61B | |
| -11.53% | 3.46B |
- Stock Market
- Equities
- 9267 Stock
